ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it.

Kanamarlapudi, Venkateswarlu; Tamaddon-Jahromi, Salman; Murphy, Kate

Kanamarlapudi, Venkateswarlu; Tamaddon-Jahromi, Salman; Murphy, Kate.

Affiliation

Kanamarlapudi V; Institute of Life Science 1, School of Medicine, Swansea University, Singleton Park, Swansea, United Kingdom.
Tamaddon-Jahromi S; Institute of Life Science 1, School of Medicine, Swansea University, Singleton Park, Swansea, United Kingdom.
Murphy K; Cellular Pathology, Swansea Bay University Health Board, Singleton Hospital, Swansea, United Kingdom.

PLoS One ; 17(2): e0263845, 2022.

Article in En | MEDLINE | ID: mdl-35143561

Subject(s)

ADP-Ribosylation Factor 6/genetics; ADP-Ribosylation Factor 6/metabolism; Adenocarcinoma/pathology; Esophageal Neoplasms/pathology; Up-Regulation; Adenocarcinoma/genetics; Adenocarcinoma/metabolism; Biomarkers, Tumor/genetics; Biomarkers, Tumor/metabolism; Case-Control Studies; Disease Progression; Esophageal Neoplasms/genetics; Esophageal Neoplasms/metabolism; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Grading; Tissue Array Analysis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Adenocarcinoma / Up-Regulation / ADP-Ribosylation Factor 6 Type of study: Observational_studies / Qualitative_research Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google